{"id":"oxycodone-hcl-controlled-release","safety":{"commonSideEffects":[{"rate":"40-50","effect":"Constipation"},{"rate":"20-30","effect":"Nausea"},{"rate":"15-25","effect":"Dizziness"},{"rate":"20-30","effect":"Drowsiness"},{"rate":"10-15","effect":"Vomiting"},{"rate":"10-15","effect":"Pruritus"},{"rate":"5-10","effect":"Headache"},{"rate":"1-5","effect":"Respiratory depression"}]},"_chembl":null,"_fixedAt":"2026-03-30T18:38:21.967550","_dailymed":{"setId":"88603d5f-4ad0-46ab-999f-740312dc35dc","title":"OXYCODONE HCL CONTROLLED-RELEASE TABLET OXYCODONE HCL CONTROLLED-RELEASE TABLET [RANBAXY PHARMACEUTICALS INC]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Oxycodone is a semi-synthetic opioid agonist that acts primarily on mu (μ) opioid receptors in the brain and spinal cord. The controlled-release formulation provides sustained drug delivery over 12 hours, maintaining steady-state plasma concentrations for prolonged pain relief. This mechanism reduces both the perception of pain and the emotional response to pain.","oneSentence":"Oxycodone HCl binds to opioid receptors in the central nervous system to block pain signal transmission and produce analgesia.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:25:16.352Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Moderate to severe chronic pain requiring continuous opioid therapy"}]},"_fixedFields":["modality→Biologic"],"trialDetails":[{"nctId":"NCT06423703","phase":"PHASE3","title":"A Study of Cebranopadol for the Treatment of Acute Pain After Bunionectomy","status":"COMPLETED","sponsor":"Tris Pharma, Inc.","startDate":"2024-07-18","conditions":"Acute Pain","enrollment":240},{"nctId":"NCT07348627","phase":"PHASE3","title":"Opioid-Sparing Joint Replacement","status":"NOT_YET_RECRUITING","sponsor":"Emory University","startDate":"2026-02","conditions":"Pain Management, Opioid Consumption","enrollment":120},{"nctId":"NCT04044820","phase":"NA","title":"Opioid Use Post-Discharge After Ambulatory Distal Arm Surgery","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2019-03-04","conditions":"Opioid Use","enrollment":292},{"nctId":"NCT03756961","phase":"NA","title":"Effects of an Opioid Free/Sparing Care Pathway for Patients Undergoing Obesity Surgery","status":"RECRUITING","sponsor":"Göteborg University","startDate":"2019-05-01","conditions":"Obesity, Pain, Postoperative","enrollment":220},{"nctId":"NCT06434233","phase":"PHASE4","title":"Opioid Use After Laparoscopic Salpingectomy","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2024-04-25","conditions":"Opioid Use, Post-operative Pain, Sterility, Female","enrollment":120},{"nctId":"NCT03823534","phase":"PHASE3","title":"Post-Op Pain Control for Prophylactic Intramedullary Nailing.","status":"RECRUITING","sponsor":"St. Louis University","startDate":"2019-02-20","conditions":"Bone Metastases, Lymphoma, Multiple Myeloma","enrollment":60},{"nctId":"NCT05842044","phase":"PHASE2","title":"NSAID Use After Robotic Partial Nephrectomy","status":"RECRUITING","sponsor":"University of Miami","startDate":"2023-09-15","conditions":"Kidney Cancer, Renal Cancer, Renal Neoplasm","enrollment":110},{"nctId":"NCT04094701","phase":"NA","title":"Hip Arthroscopy Postoperative Opioid Demands","status":"RECRUITING","sponsor":"Rush University Medical Center","startDate":"2020-10-21","conditions":"Opioid Use, Pain, Femoral Acetabular Impingement","enrollment":170},{"nctId":"NCT07001709","phase":"PHASE4","title":"Determining the Effect of Abiraterone on the Metabolism of Oxycodone in Men With Prostate Cancer (the ENABLE Study)","status":"RECRUITING","sponsor":"Deventer Ziekenhuis","startDate":"2024-04-12","conditions":"Prostate Cancer, Pain Cancer","enrollment":29},{"nctId":"NCT05070338","phase":"NA","title":"Postoperative Nudges to Reduce Opioid Prescribing","status":"COMPLETED","sponsor":"RAND","startDate":"2021-10-19","conditions":"Opioid Prescribing","enrollment":640},{"nctId":"NCT06864312","phase":"PHASE4","title":"Rebound Pain Following Regional Anaesthesia for Ankle Fracture Surgery","status":"COMPLETED","sponsor":"University College Cork","startDate":"2023-10-16","conditions":"Ankle Fracture (bimalleolar Equivalent, Bimalleolar, or Trimalleolar), Ankle Fracture - Lateral Malleolus, Ankle Fracture - Medial Malleolus","enrollment":120},{"nctId":"NCT03987022","phase":"PHASE4","title":"ICE-T Pain Regimen for Total Laparoscopic Hysterectomy","status":"COMPLETED","sponsor":"MetroHealth Medical Center","startDate":"2019-08-01","conditions":"Opioid Substitution Treatment","enrollment":66},{"nctId":"NCT05567354","phase":"PHASE1","title":"A Study to Evaluate the Intranasal Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-103)","status":"COMPLETED","sponsor":"Ensysce Biosciences","startDate":"2022-06-10","conditions":"Recreational Drug Use","enrollment":27},{"nctId":"NCT05571345","phase":"PHASE1","title":"A Study to Evaluate the Oral Abuse Potential of PF614 in Non-Dependent Recreational Opioid Users (PF614-104)","status":"COMPLETED","sponsor":"Ensysce Biosciences","startDate":"2022-10-05","conditions":"Recreational Drug Use","enrollment":32},{"nctId":"NCT06561035","phase":"PHASE3","title":"ACL-R Opioid Sparing Study","status":"ENROLLING_BY_INVITATION","sponsor":"Campbell Clinic","startDate":"2024-09-01","conditions":"Anterior Cruciate Ligament Injuries","enrollment":56},{"nctId":"NCT04811209","phase":"","title":"MCID and PASS for Acute Pain and Quality of Recovery After Orthopedic Surgery","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2021-06-21","conditions":"Pain Management","enrollment":300},{"nctId":"NCT05363436","phase":"PHASE4","title":"Opioid Reduction Toolkit Reduces Opioids Prescribed and Consumed","status":"SUSPENDED","sponsor":"Thomas Jefferson University","startDate":"2018-01-01","conditions":"Opioid Abuse, Opioid Misuse, Pain","enrollment":159},{"nctId":"NCT05252858","phase":"NA","title":"A Pilot Study Investigating the nCAP Signal Relief Patch in Subjects Undergoing Primary Hip or Knee Replacement Surgery","status":"COMPLETED","sponsor":"Jacques E. Chelly","startDate":"2022-03-21","conditions":"Opioid Use, Pain, Post Operative","enrollment":79},{"nctId":"NCT03867539","phase":"PHASE4","title":"Exparel and Education to Avoid Opioids After Carpal Tunnel Release","status":"RECRUITING","sponsor":"Kettering Health Network","startDate":"2019-02-15","conditions":"Carpal Tunnel Syndrome","enrollment":64},{"nctId":"NCT06227208","phase":"","title":"Postoperative Opioid and Respiratory Depression in Opioid Naive and Chronic Opioid Patients","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","startDate":"2023-10-01","conditions":"Medical Complication","enrollment":691},{"nctId":"NCT04429022","phase":"PHASE3","title":"Multimodal Pain Management After Robotic-Assisted Total Laparoscopic Hysterectomy","status":"COMPLETED","sponsor":"State University of New York at Buffalo","startDate":"2020-11-24","conditions":"Pain, Postoperative","enrollment":68},{"nctId":"NCT05389813","phase":"PHASE2, PHASE3","title":"Comparison Between Oxycodone and Pregabalin as Preemptive Analgesia","status":"UNKNOWN","sponsor":"An-Najah National University","startDate":"2021-08-15","conditions":"Anesthesia","enrollment":150},{"nctId":"NCT05327777","phase":"PHASE4","title":"Toward Zero Prescribed Opioids for Outpatient General Surgery","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2019-11-01","conditions":"Opioid Misuse and Addiction, Pain","enrollment":129},{"nctId":"NCT04710277","phase":"NA","title":"Novel Multimodal Pain Control Protocol for Minimally Invasive Gynecologic Surgery","status":"COMPLETED","sponsor":"Ohio State University","startDate":"2021-04-19","conditions":"Postoperative Pain, Narcotic Use, Cryotherapy Effect","enrollment":54},{"nctId":"NCT04464512","phase":"PHASE4","title":"Suboxone User Perioperative Early Referral and Enhanced Recovery After Surgery- Orthopaedic Trauma Surgery Population","status":"WITHDRAWN","sponsor":"West Virginia University","startDate":"2020-01-10","conditions":"Addiction Opiate, Chronic Pain, Fractures, Bone","enrollment":""},{"nctId":"NCT03471442","phase":"NA","title":"Erector Spinae Plane Block Versus Paravertebral Block","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2018-05-29","conditions":"Breast Cancer, Pain, Postoperative, Anesthesia, Local","enrollment":48},{"nctId":"NCT04522206","phase":"PHASE4","title":"An Analysis of the Efficacy of a Pre-Emptive Multimodal Pain Regimen in Reducing Acute Post-Operative Pain and Narcotic Pain Medication Requirements in Spine Surgery","status":"COMPLETED","sponsor":"NYU Langone Health","startDate":"2020-08-20","conditions":"Pain, Postoperative, Spine Injuries and Disorders, Narcotic Use","enrollment":44},{"nctId":"NCT04808531","phase":"PHASE3","title":"NanaBis™ an Oro-buccal Administered delta9-Tetrahydrocannabinol (d9-THC) & Cannabidiol (CBD) Medicine for the Management of Bone Pain From Metastatic Cancers","status":"UNKNOWN","sponsor":"Medlab Clinical","startDate":"2023-11","conditions":"Cancer Related Pain","enrollment":360},{"nctId":"NCT04246541","phase":"PHASE3","title":"Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic Meniscus Surgery","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2019-04-23","conditions":"Meniscus Tear, Tibial, Pain, Postoperative, Postoperative Complications","enrollment":48},{"nctId":"NCT04246554","phase":"PHASE3","title":"Ketorolac as an Adjuvant Agent for Postoperative Pain Control Following Arthroscopic ACL Surgery","status":"COMPLETED","sponsor":"University Hospitals Cleveland Medical Center","startDate":"2019-05-21","conditions":"ACL Injury, Postoperative Pain","enrollment":49},{"nctId":"NCT02351700","phase":"PHASE4","title":"Analgesia Regimens Following Trans-sphenoidal Surgery for Pituitary Tumors","status":"COMPLETED","sponsor":"St. Joseph's Hospital and Medical Center, Phoenix","startDate":"2015-02-01","conditions":"Pituitary Tumor, Pain","enrollment":62},{"nctId":"NCT02740114","phase":"PHASE3","title":"Wound Infiltration With Liposomal Bupivacaine vs. Standard Wound Infiltration With Bupivacaine in Patient's Undergoing Open Gynecologic Surgery on an Enhanced Recovery Pathway","status":"TERMINATED","sponsor":"M.D. Anderson Cancer Center","startDate":"2016-08-31","conditions":"Malignant Neoplasms of Female Genital Organs, Gynecologic Cancer","enrollment":105},{"nctId":"NCT03586934","phase":"PHASE3","title":"Multimodal Analgesia in Shoulder Arthroplasty","status":"WITHDRAWN","sponsor":"Rush University Medical Center","startDate":"2018-06-01","conditions":"Shoulder Pain, Opioid Use","enrollment":""},{"nctId":"NCT03175653","phase":"NA","title":"Impact of the Number of Opiates Prescribed on Post Cesarean Pain Control","status":"WITHDRAWN","sponsor":"Mount Carmel Health System","startDate":"2017-06-16","conditions":"Post-operative Pain Control","enrollment":""},{"nctId":"NCT03639415","phase":"PHASE4","title":"Change the Dose Frequency of Controlled-Release Oxycodone to Refractory Pain","status":"WITHDRAWN","sponsor":"Fujian Cancer Hospital","startDate":"2018-10-30","conditions":"Cancer Pains","enrollment":""},{"nctId":"NCT03768466","phase":"PHASE4","title":"Efficacy and Safety of Oxycodone/Naloxone (Targin®) in Persistent Moderate to Severe Low Back Pain Following NSAIDs Treatment","status":"COMPLETED","sponsor":"Mundipharma Korea Ltd","startDate":"2018-11-21","conditions":"Low Back Pain","enrollment":123},{"nctId":"NCT02659501","phase":"NA","title":"Liposomal Bupivacaine in Implant Based Breast Reconstruction","status":"TERMINATED","sponsor":"Loma Linda University","startDate":"2015-07","conditions":"Breast Cancer, Postoperative Pain","enrollment":24},{"nctId":"NCT03355248","phase":"NA","title":"Satisfaction Following Cesarean Section","status":"COMPLETED","sponsor":"ProMedica Health System","startDate":"2017-08-18","conditions":"Pain, Postoperative, Cesarean Section Complications, Postpartum Disorder","enrollment":60},{"nctId":"NCT03845881","phase":"EARLY_PHASE1","title":"Trial Comparing a Multi-Modal Pain Protocol With and Without Opioids Following Total Joint Arthroplasty","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2019-04-10","conditions":"Total Knee Arthroplasty","enrollment":45},{"nctId":"NCT04448457","phase":"NA","title":"Sufentanil Sublingual Tablet System for Postoperative Pain Management After Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire de Tivoli","startDate":"2017-09-01","conditions":"Postoperative Pain","enrollment":72},{"nctId":"NCT04132011","phase":"PHASE4","title":"Dosing Intervals of Opioid Medication for Chronic Pain","status":"WITHDRAWN","sponsor":"University Health Network, Toronto","startDate":"2019-05-01","conditions":"Chronic Pain","enrollment":""},{"nctId":"NCT03570320","phase":"NA","title":"Does Altering Narcotic Prescription Methods Affect Opioid Distribution Following Select Upper Extremity Surgeries?","status":"COMPLETED","sponsor":"John Yanik","startDate":"2018-09-04","conditions":"Opioid Use","enrollment":48},{"nctId":"NCT01192295","phase":"PHASE3","title":"Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids","status":"COMPLETED","sponsor":"Purdue Pharma LP","startDate":"2010-11","conditions":"Pain","enrollment":155},{"nctId":"NCT03176121","phase":"PHASE4","title":"Study Evaluating Safety and Tolerability of Oxycodone in Patients With Moderate to Severe Cancer Pain","status":"COMPLETED","sponsor":"Taiwan Mundipharma Pharmaceuticals Ltd.","startDate":"2016-10-31","conditions":"Cancer, Pain","enrollment":73},{"nctId":"NCT03176199","phase":"PHASE4","title":"A Study to Compare the Titration Efficacy and Safety of Control-released Oxycodone and Immediate-released Oxycodone in Patients With Moderate to Severe Cancer Pain","status":"COMPLETED","sponsor":"Taiwan Mundipharma Pharmaceuticals Ltd.","startDate":"2016-09-01","conditions":"Cancer, Pain","enrollment":30},{"nctId":"NCT03319277","phase":"NA","title":"A Randomized-controlled Trial of Post-operative Opiate Quantities After Urogynecologic Surgery","status":"COMPLETED","sponsor":"The Cleveland Clinic","startDate":"2017-10-13","conditions":"Postoperative Pain, Opioid Use","enrollment":118},{"nctId":"NCT00486811","phase":"PHASE3","title":"A Study to Evaluate the Efficacy and Safety of CG5503 Prolonged Release (PR) in Subjects With Moderate to Severe Chronic Pain Due to Osteoarthritis of the Knee","status":"COMPLETED","sponsor":"Grünenthal GmbH","startDate":"2007-06","conditions":"Pain, Knee Osteoarthritis","enrollment":990},{"nctId":"NCT03478423","phase":"NA","title":"Opioid Analgesics for Acute Fracture Pain in Adults Discharged From the ED","status":"TERMINATED","sponsor":"Mount Sinai Hospital, Canada","startDate":"2018-02-05","conditions":"Acute Pain","enrollment":5},{"nctId":"NCT04102566","phase":"PHASE4","title":"Optimizing Pain Control in Transurethral Resection of the Prostate","status":"RECRUITING","sponsor":"Benaroya Research Institute","startDate":"2017-12-08","conditions":"Pain, BPH With Urinary Obstruction, BPH With Urinary Obstruction With Other Lower Urinary Tract Symptoms","enrollment":50},{"nctId":"NCT03059238","phase":"PHASE3","title":"Parecoxib Versus Celecoxib Versus Oxycodone in Pain Control for Transcatheter Chemoembolization Procedure","status":"COMPLETED","sponsor":"Sun Yat-sen University","startDate":"2016-09","conditions":"Liver Cancer, Pain Postoperative","enrollment":213},{"nctId":"NCT03372382","phase":"PHASE4","title":"Ibuprofen and Acetaminophen Versus Ibuprofen and Acetaminophen Plus Hydrocodone for Analgesia After Cesarean Section","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2017-12-13","conditions":"Opioid Use, Pain, Postoperative","enrollment":170},{"nctId":"NCT04003350","phase":"NA","title":"The Effect of Prolonged Multimodal Analgesic Regimen on Post Hospital Discharge Opioid Use and Pain Control After Primary Total Knee Arthroplasty","status":"COMPLETED","sponsor":"Rothman Institute Orthopaedics","startDate":"2017-12-21","conditions":"Osteo Arthritis Knee","enrollment":216},{"nctId":"NCT03996564","phase":"NA","title":"Battlefield Acupuncture for Acute/Subacute Back Pain in the Emergency Department","status":"COMPLETED","sponsor":"San Antonio Military Medical Center","startDate":"2016-02-22","conditions":"Low Back Pain, Mechanical","enrollment":26},{"nctId":"NCT03168425","phase":"NA","title":"Opioid Prescribing After Cesarean Delivery","status":"COMPLETED","sponsor":"Vanderbilt University Medical Center","startDate":"2017-06-14","conditions":"Surgery, Opioid Use","enrollment":190},{"nctId":"NCT03828981","phase":"NA","title":"A Fast-track Versus Conventional Recovery Protocol in Laparoscopic Hysterctomy","status":"COMPLETED","sponsor":"Helsinki University Central Hospital","startDate":"2016-05-31","conditions":"Gynecologic Surgery","enrollment":120},{"nctId":"NCT03358888","phase":"NA","title":"Prolonged Multimodal Analgesia for Post-Discharge Pain Control After Primary Total Hip Arthroplasty","status":"COMPLETED","sponsor":"Rothman Institute Orthopaedics","startDate":"2017-06-05","conditions":"Osteoarthritis, Hip","enrollment":228},{"nctId":"NCT02132416","phase":"NA","title":"Operative Treatment of Unstable Thoracic Cage Injuries and Chest Wall Deformity in Trauma","status":"COMPLETED","sponsor":"Sahlgrenska University Hospital","startDate":"2014-05","conditions":"Trauma, Flail Chest, Rib Fractures","enrollment":92},{"nctId":"NCT03765346","phase":"PHASE1","title":"A Comparison of How Likely it is That Different Tablets of Oxycodone Will be Broken up and Snorted by Adults Who Sometimes Take Drugs for Pleasure","status":"COMPLETED","sponsor":"Grünenthal GmbH","startDate":"2018-07-24","conditions":"Substance Abuse","enrollment":123},{"nctId":"NCT00743587","phase":"PHASE1","title":"A Study To Assess The Ability Of Tramadol, Naproxen And Oxycodone To Affect The Pain Thresholds Of Patients With Osteoarthritis Of The Thumb","status":"COMPLETED","sponsor":"Pfizer","startDate":"2008-09","conditions":"Osteoarthritis Thumbs","enrollment":36},{"nctId":"NCT00513656","phase":"PHASE2","title":"A Study Comparing Oxycodone to Oxycodone/Naloxone in Moderate to Severe, Chronic Cancer Pain","status":"COMPLETED","sponsor":"Mundipharma Research GmbH & Co KG","startDate":"2007-09","conditions":"Cancer, Pain, Constipation","enrollment":230},{"nctId":"NCT01197261","phase":"PHASE2","title":"OXN PR vs Placebo in Opioid-naive Subjects Suffering From Severe Pain Due to Bladder Pain Syndrome (BPS)","status":"COMPLETED","sponsor":"Mundipharma Research GmbH & Co KG","startDate":"2010-09","conditions":"Interstitial Cystitis, Painful Bladder Syndrome, Pain","enrollment":120},{"nctId":"NCT01971632","phase":"PHASE3","title":"A Randomised, Double Blind, Placebo and Active Controlled, Double Dummy,Parallel Group Study to Determine the Safety and Efficacy of Oxycodone/Naloxone Prolonged Release Tablets in Subjects With Moderate to Severe, Chronic Nonmalignant Pain","status":"COMPLETED","sponsor":"Mundipharma Research GmbH & Co KG","startDate":"2005-01","conditions":"Subjects With Moderate to Severe, Chronic Nonmalignant Pain","enrollment":463},{"nctId":"NCT01112644","phase":"PHASE3","title":"Oxycodone/Naloxone Prolonged Release (OXN PR) Compared to Placebo to Demonstrate Improvement in Symptoms of Restless Legs Syndrome (RLS) in Subjects With Moderate to Severe Idiopathic RLS With Daytime Symptoms","status":"COMPLETED","sponsor":"Mundipharma Research GmbH & Co KG","startDate":"2010-04","conditions":"Moderate to Severe Idiopathic RLS With Daytime Symptoms","enrollment":205},{"nctId":"NCT01746901","phase":"PHASE1","title":"A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Abusers","status":"COMPLETED","sponsor":"Pfizer","startDate":"2013-02","conditions":"Healthy","enrollment":81},{"nctId":"NCT01677065","phase":"","title":"A Randomized, Two-way, Crossover Study to Estimate the Relative Bioavailability of a Controlled-release Formulation of Oxycodone (40 mg) With Sequestered Naltrexone Compared With Immediate-release Oxycodone Tablets (20 mg) in Healthy Volunteers","status":"COMPLETED","sponsor":"Pfizer","startDate":"2012-09","conditions":"Healthy","enrollment":14},{"nctId":"NCT02680847","phase":"PHASE4","title":"Safety and Pharmacokinetic Study of ALO-02 in Children Ages 7-17 With Pain","status":"TERMINATED","sponsor":"Pfizer","startDate":"2016-01-21","conditions":"Moderate-severe Pain","enrollment":32},{"nctId":"NCT03475862","phase":"PHASE1","title":"Nasal Human Abuse Potential of PTI-821","status":"COMPLETED","sponsor":"Pain Therapeutics","startDate":"2017-05-15","conditions":"Opioid Abuse Nondependent","enrollment":38},{"nctId":"NCT02716857","phase":"PHASE3","title":"Efficacy and Safety of Egalet-002 in Patients With Moderate-to-Severe Chronic Low Back Pain","status":"COMPLETED","sponsor":"Egalet Ltd","startDate":"2016-03","conditions":"Moderate-to-severe Chronic Low Back Pain","enrollment":549},{"nctId":"NCT01631513","phase":"PHASE4","title":"An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)","status":"WITHDRAWN","sponsor":"Janssen Scientific Affairs, LLC","startDate":"2012-08","conditions":"Pain, Chronic Back Pain, Chronic Low Back Pain","enrollment":""},{"nctId":"NCT03045484","phase":"NA","title":"Comparison of Oxycodone to Control Moderate or Severe Oral Mucositis Pain Induced by Chemoradiotherapy","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2016-05","conditions":"Nasopharyngeal Carcinoma","enrollment":70},{"nctId":"NCT00955110","phase":"PHASE4","title":"Study to Compare Oxymorphone Extended-Release (Opana ER) Versus Oxycodone Controlled-Release (Oxycontin)","status":"COMPLETED","sponsor":"Endo Pharmaceuticals","startDate":"2009-06","conditions":"Healthy","enrollment":78},{"nctId":"NCT00679614","phase":"PHASE3","title":"Effect of Combined Use of Naloxone and Tramacet on Postop Analgesia in Elderly Patients Having Joint Replacement Surgery","status":"COMPLETED","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","startDate":"2007-12-17","conditions":"Hip Arthroplasty, Knee Arthroplasty, Spinal Anesthesia","enrollment":45},{"nctId":"NCT01165281","phase":"PHASE3","title":"A Safety and Efficacy Study of JNS024 Extended Release (ER) in Japanese and Korean Patients With Chronic Malignant Tumor-Related Cancer Pain","status":"COMPLETED","sponsor":"Janssen Research & Development, LLC","startDate":"2010-08","conditions":"Pain","enrollment":343},{"nctId":"NCT01775189","phase":"PHASE1","title":"A Study to Characterize the Abuse Liability of ALO-02 in Healthy, Non-Dependent, Recreational Opioid Users When ALO-02 Capsules Are Crushed and Snorted","status":"COMPLETED","sponsor":"Pfizer","startDate":"2013-02","conditions":"Healthy","enrollment":45},{"nctId":"NCT01571362","phase":"PHASE3","title":"A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain","status":"COMPLETED","sponsor":"Pfizer","startDate":"2012-06","conditions":"Chronic Pain, Low Back Pain, Analgesia","enrollment":410},{"nctId":"NCT00853892","phase":"PHASE1","title":"Fasting Study of Controlled-Release Oxycodone Hydrochloride 40 mg Tablets and OxyContin® 40 mg Tablets","status":"COMPLETED","sponsor":"Mallinckrodt","startDate":"2005-04","conditions":"Healthy","enrollment":34},{"nctId":"NCT00853268","phase":"PHASE1","title":"Fed Study of Controlled-Release Oxycodone Hydrochloride 40 mg Tablets and OxyContin® 40 mg Tablets","status":"COMPLETED","sponsor":"Mallinckrodt","startDate":"2005-04","conditions":"Healthy","enrollment":34},{"nctId":"NCT01986283","phase":"PHASE1","title":"Abuse Potential Study of PF-00345439","status":"COMPLETED","sponsor":"Pain Therapeutics","startDate":"2013-11","conditions":"Opioid Users","enrollment":67},{"nctId":"NCT02307305","phase":"PHASE2","title":"Does Duloxetine Reduce Chronic Pain After Total Knee Arthroplasty?","status":"UNKNOWN","sponsor":"Hanyang University Seoul Hospital","startDate":"2014-08","conditions":"Neuropathic Pain","enrollment":168},{"nctId":"NCT00580294","phase":"NA","title":"A Pilot Study of Switching From One Pain Medication to Another (Opioid Rotation)","status":"COMPLETED","sponsor":"Icahn School of Medicine at Mount Sinai","startDate":"2007-11","conditions":"Pain","enrollment":12},{"nctId":"NCT01358526","phase":"PHASE3","title":"Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain","status":"COMPLETED","sponsor":"Purdue Pharma LP","startDate":"2011-05","conditions":"Low Back Pain","enrollment":1095},{"nctId":"NCT02600247","phase":"NA","title":"Effects of Duloxetine on Pain Relief After Total Knee Arthroplasty in Central Sensitization Patient","status":"UNKNOWN","sponsor":"The Catholic University of Korea","startDate":"2015-11","conditions":"Osteoarthritis","enrollment":100},{"nctId":"NCT01608308","phase":"NA","title":"Intraoperative and Post-operative Analgesic Effect of IV Acetaminophen for Sinus Surgery","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2012-07","conditions":"Chronic Sinusitis","enrollment":62},{"nctId":"NCT01014559","phase":"PHASE3","title":"Efficacy of Oxycodone/Naloxone(OXN), Versus Oxycodone (OXY), for the Reduction of Intensity of Opioid-induced Constipation in Pain Patients","status":"TERMINATED","sponsor":"Mundipharma SAS","startDate":"2010-02","conditions":"Constipation, Pain","enrollment":225},{"nctId":"NCT01369615","phase":"PHASE3","title":"Long-Term Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children Who Completed OTR3001","status":"COMPLETED","sponsor":"Purdue Pharma LP","startDate":"2011-10","conditions":"Pain","enrollment":23},{"nctId":"NCT00979953","phase":"PHASE2","title":"Efficacy and Safety Study Evaluating ADL5859 and ADL5747 in Participants With Pain Due to Osteoarthritis of the Knee","status":"COMPLETED","sponsor":"Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)","startDate":"2009-10","conditions":"Osteoarthritis of the Knee","enrollment":408},{"nctId":"NCT02452437","phase":"PHASE4","title":"Opioids in Chronic Kidney Disease Patients Undergoing Hemodialysis","status":"UNKNOWN","sponsor":"Emerio & Lourdes Linares Research and Education Center","startDate":"2015-05","conditions":"Chronic Kidney Disease","enrollment":20},{"nctId":"NCT01427283","phase":"PHASE3","title":"A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain","status":"COMPLETED","sponsor":"Purdue Pharma LP","startDate":"2011-08","conditions":"Low Back Pain","enrollment":450},{"nctId":"NCT02101840","phase":"PHASE4","title":"Abuse Liability of Controlled-Release Oxycodone Formulations","status":"COMPLETED","sponsor":"Centre for Addiction and Mental Health","startDate":"2014-02","conditions":"Substance-Related Disorders","enrollment":11},{"nctId":"NCT01779492","phase":"PHASE1","title":"A Randomized, Open-label, Multiple-dose, Two-sequence, Two-period Crossover Study to Investigate The Pharmacokinetics Between a GL2907 and Oxycontin CR Tab. 10mg in Healthy Male Volunteers","status":"COMPLETED","sponsor":"GL Pharm Tech Corporation","startDate":"2013-04","conditions":"Healthy","enrollment":24},{"nctId":"NCT01427270","phase":"PHASE3","title":"Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) for Uncontrolled Moderate - Severe Low Back Pain","status":"COMPLETED","sponsor":"Purdue Pharma LP","startDate":"2011-08","conditions":"Low Back Pain","enrollment":455},{"nctId":"NCT02152592","phase":"PHASE4","title":"Controlled-Release Oxycodone Versus Naproxen at Home After Ambulatory Surgery: A Randomized Controlled Trial","status":"COMPLETED","sponsor":"Maastricht University Medical Center","startDate":"2007-10","conditions":"Postoperative Pain After Ambulatory Surgery","enrollment":105},{"nctId":"NCT00771758","phase":"PHASE3","title":"Tapentadol IR vs Oxycodone IR vs Placebo in Acute Pain From Vertebral Compression Fracture Associated With Osteoporosis","status":"COMPLETED","sponsor":"Ortho-McNeil Janssen Scientific Affairs, LLC","startDate":"2008-09","conditions":"Back Pain","enrollment":108},{"nctId":"NCT00613938","phase":"PHASE3","title":"A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) in the Treatment of Acute Pain From Bunionectomy.","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2008-02","conditions":"Arthralgia, Bunion, Hallux Valgus","enrollment":901},{"nctId":"NCT00361504","phase":"PHASE3","title":"A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic Pain","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2006-11","conditions":"Osteoarthritis, Hip, Osteoarthritis, Knee, Lower Back Pain","enrollment":1123},{"nctId":"NCT00364533","phase":"PHASE3","title":"A Study to Evaluate the Effectiveness and Safety of Tapentadol(CG5503) in the Treatment of Acute Pain After Hip Replacement Surgery Compared With Oxycodone and Placebo Followed by a Voluntary Open-Label Extension For Safety","status":"TERMINATED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2006-10","conditions":"Arthroplasty","enrollment":367},{"nctId":"NCT01063868","phase":"PHASE3","title":"A Long-term Safety Study With Tapentadol ER and Oxycodone CR in Patients With Moderate to Severe Pain Due to Chronic, Painful Diabetic Peripheral Neuropathy (DPN)","status":"TERMINATED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2010-01","conditions":"Diabetic Neuropathy, Painful, Diabetic Polyneuropathy","enrollment":47},{"nctId":"NCT01439100","phase":"PHASE3","title":"A Randomised Placebo Controlled Study of OXN PR for Severe Parkinson's Disease Associated Pain","status":"COMPLETED","sponsor":"Mundipharma Research GmbH & Co KG","startDate":"2011-10","conditions":"Parkinson's Disease With Severe Pain","enrollment":172},{"nctId":"NCT01205126","phase":"PHASE3","title":"An Efficacy and Safety Study of Oral Osmotic Therapeutic System (OROS) Hydromorphone Hydrochloride (HCl) in Participants With Cancer Related Pain","status":"COMPLETED","sponsor":"Johnson & Johnson Pharmaceutical Research & Development, L.L.C.","startDate":"2009-12","conditions":"Pain","enrollment":260},{"nctId":"NCT00583869","phase":"EARLY_PHASE1","title":"Role of Pregabalin in Treatment of Post-Op Pain in Fracture Patients","status":"COMPLETED","sponsor":"University of Alabama at Birmingham","startDate":"2007-05","conditions":"Post-operative Pain","enrollment":86}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":15,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["OxyContin"],"phase":"marketed","status":"active","brandName":"Oxycodone HCl controlled-release","genericName":"Oxycodone HCl controlled-release","companyName":"Purdue Pharma LP","companyId":"purdue-pharma-lp","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Oxycodone HCl binds to opioid receptors in the central nervous system to block pain signal transmission and produce analgesia. Used for Moderate to severe chronic pain requiring continuous opioid therapy.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}